Gamco Investors INC. ET AL decreased its position in Masimo Co. (NASDAQ:MASI) by 2.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 122,500 shares of the medical equipment provider’s stock after selling 2,500 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Masimo were worth $10,388,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also recently added to or reduced their stakes in MASI. Koch Industries Inc. lifted its position in Masimo by 5,053.7% in the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after buying an additional 435,325 shares during the last quarter. Victory Capital Management Inc. bought a new stake in Masimo in the 3rd quarter worth approximately $26,049,000. American Century Companies Inc. lifted its position in Masimo by 127.7% in the 3rd quarter. American Century Companies Inc. now owns 476,963 shares of the medical equipment provider’s stock worth $41,286,000 after buying an additional 267,489 shares during the last quarter. Old Mutual Global Investors UK Ltd. lifted its position in Masimo by 41.9% in the 3rd quarter. Old Mutual Global Investors UK Ltd. now owns 808,488 shares of the medical equipment provider’s stock worth $69,982,000 after buying an additional 238,601 shares during the last quarter. Finally, State Street Corp lifted its position in Masimo by 10.4% in the 2nd quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after buying an additional 146,212 shares during the last quarter. Institutional investors own 82.57% of the company’s stock.
Masimo Co. (NASDAQ:MASI) opened at $82.06 on Friday. The company has a market capitalization of $4,427.18, a P/E ratio of 32.83, a price-to-earnings-growth ratio of 3.26 and a beta of 0.85. Masimo Co. has a 12 month low of $75.06 and a 12 month high of $104.71.
MASI has been the subject of a number of recent research reports. Stifel Nicolaus restated a “buy” rating and issued a $108.00 target price on shares of Masimo in a research report on Friday, November 3rd. Zacks Investment Research raised Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a research note on Thursday, November 2nd. Finally, BidaskClub cut Masimo from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $97.17.
COPYRIGHT VIOLATION NOTICE: “Gamco Investors INC. ET AL Sells 2,500 Shares of Masimo Co. (MASI)” was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.com-unik.info/2018/02/09/gamco-investors-inc-et-al-sells-2500-shares-of-masimo-co-masi.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.